Your browser doesn't support javascript.
loading
PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors.
Ohki, Rieko; Saito, Kozue; Chen, Yu; Kawase, Tatsuya; Hiraoka, Nobuyoshi; Saigawa, Raira; Minegishi, Maiko; Aita, Yukie; Yanai, Goichi; Shimizu, Hiroko; Yachida, Shinichi; Sakata, Naoaki; Doi, Ryuichiro; Kosuge, Tomoo; Shimada, Kazuaki; Tycko, Benjamin; Tsukada, Toshihiko; Kanai, Yae; Sumi, Shoichiro; Namiki, Hideo; Taya, Yoichi; Shibata, Tatsuhiro; Nakagama, Hitoshi.
Affiliation
  • Ohki R; Divisions of Refractory Cancer Research, rohki@ncc.go.jp.
  • Saito K; Divisions of Refractory Cancer Research,Graduate School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, Japan;
  • Chen Y; Divisions of Refractory Cancer Research,Graduate School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, Japan;
  • Kawase T; Radiobiology.
  • Hiraoka N; Molecular Pathology.
  • Saigawa R; Divisions of Refractory Cancer Research,Graduate School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, Japan;
  • Minegishi M; Divisions of Refractory Cancer Research,Graduate School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, Japan;
  • Aita Y; Divisions of Refractory Cancer Research.
  • Yanai G; Department of Organ Reconstruction, Institute for Frontier Medical Sciences, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan;
  • Shimizu H; Cancer Genomics, and.
  • Yachida S; Divisions of Refractory Cancer Research.
  • Sakata N; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai 980-8575, Miyagi, Japan;
  • Doi R; Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan;
  • Kosuge T; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan;
  • Shimada K; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan;
  • Tycko B; Institute for Cancer Genetics, Columbia University, New York, NY 10032; and.
  • Tsukada T; Familial Cancer Research, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan;
  • Kanai Y; Molecular Pathology.
  • Sumi S; Department of Organ Reconstruction, Institute for Frontier Medical Sciences, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan;
  • Namiki H; Graduate School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, Japan;
  • Taya Y; Radiobiology,Cancer Research Center of Excellence, Center for Life Sciences, National University of Singapore, Singapore 117456.
  • Shibata T; Cancer Genomics, and.
  • Nakagama H; Divisions of Refractory Cancer Research.
Proc Natl Acad Sci U S A ; 111(23): E2404-13, 2014 Jun 10.
Article in En | MEDLINE | ID: mdl-24912192
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Nuclear Proteins / Genes, Tumor Suppressor / Neuroendocrine Tumors / Loss of Heterozygosity Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Proc Natl Acad Sci U S A Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Nuclear Proteins / Genes, Tumor Suppressor / Neuroendocrine Tumors / Loss of Heterozygosity Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Proc Natl Acad Sci U S A Year: 2014 Type: Article